PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

Amgen and Kyowa Kirin agree to jointly develop eczema med

Amgen and Kyowa Kirin have signed an agreement to jointly develop and commercialise KHK4083, a monoclonal antibody (mAb) in development for the treatment of atopic d...
Continue Reading →
News

Cosentyx approved to treat plaque psoriasis in paediatric patients

The US Food and Drug Administration (FDA) has approved Novartis’ interleukin-17A (IL-17A) inhibitor Cosentyx for the treatment of children and adolescents with moder...
Continue Reading →
News

Janssen’s myeloma CAR T therapy cilta-cel demonstrates ‘sustained efficacy’

Janssen has reported new data for its B-cell maturation antigen (BCMA) directed CAR T therapy ciltacabtagene autoleucel (cilta-cel) in heavily pretreated relapsed/re...
Continue Reading →
News

FDA approves Alkermes’ Lybalvi for schizophrenia and bipolar I disorder

Alkermes’ oral atypical antipsychotic drug Lybalvi has received approval from the US Food and Drug Administration for the treatment of schizophrenia and bipolar I di...
Continue Reading →
News

WHO validates Sinovac COVID-19 vaccine for emergency use and issues interim policy recommendations

WHO today validated the Sinovac-CoronaVac COVID-19 vaccine for emergency use, giving countries, funders, procuring agencies and communities the assurance that it mee...
Continue Reading →
News

ACG makes two significant European appointments

Integrated pharma supplier strengthens its global footprint with new design heads appointed in Germany ACG, the world’s most integrated pharmaceutical supplier, appo...
Continue Reading →
News

EC approves Ponvory for relapsing MS

The European Commission (EC) has cleared Janssen’s Ponvory for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS) with active disease. ...
Continue Reading →
News

Takeda’s dengue vaccine bags positive long-term efficacy results

Japanese pharma company Takeda has announced that its dengue vaccine candidate TAK-003 demonstrated continued protection through three years after vaccination, regar...
Continue Reading →
News

Opdivo plus Yervoy moves closer to EU approval for dMMR/MSI-H colorectal cancer

Bristol Myers Squibb’s (BMS) Opdivo plus Yervoy combination therapy has moved closer to EU approval for certain colorectal cancer patients, after scoring a positive ...
Continue Reading →
News

NICE guidance gives patients with rare blood disorders access to new treatment

The National Institute for Health and Care Excellence (NICE) has recommended Alexion Pharmaceuticals’ ravulizumab (Ultomiris) as a treatment for paroxysmal nocturnal...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026